Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Merck KGaA discloses novel ET antagonists

July 29, 1997

Calcium supplementation does not prevent life-threatening disorder of pregnancy

July 28, 1997

NPY antagonists from Thomae

July 25, 1997

Phosphodiesterase inhibitors from Schering-Plough

July 24, 1997

NPY antagonists developed at Thomae

July 24, 1997

New alinidine analogues described

July 24, 1997

Teva's generic antihypertensive combination tentatively approved

July 23, 1997

Takeda's Atacand scheduled for European launch later this year

July 22, 1997

Low-dose diuretic prevents heart failure in the elderly

July 21, 1997

Selective 15-LO inhibitor effective in animal model of atherosclerosis

July 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.